Prime Therapeutics

Pharmacy Benefit Management

Based in MN

🤖

AI Overview

With $828K in lobbying spend across 29 quarterly filings, Prime Therapeutics is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2019 to 2025.

$828K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2019	$108K
2020	$120K
2021	$120K
2022	$120K
2023	$120K
2024	$120K
2025	$120K

Issues Lobbied

Health Issues Medicare/Medicaid Budget/Appropriations

Lobbying Firms

Government Counsel, LLC

Lobbyists

Henry Menn

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Budget/Appropriations

•Issues relating to pharmaceutical value-based contracting and rebate transparency.

•H.R 1781- Payment Commission Data Act of 2019; H.R. 965 & S. 340-The CREATES Act of 2019; issues relating to orphan drug exclusivity and value-based contracting; RIN 0936-AA08: Fraud and Abuse; Remova

•General issues relating to PBM point of sale rebates, spread pricing and price transparency.

•RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in

•H.R. 2113-Prescription Drug STAR Act of 2019;H.R. 2296-More Efficient Tools to Realize Information for Consumers (METRIC) Act;S. 1895-Lower Health Care Costs ActSection 306;S. 2543-The Prescription Dr